Preclinical CRO Market Size is expected to reach USD 11.8 billion by 2034
The preclinical CRO
market was valued at USD 2.42 billion in 2024 and is expected to reach
USD 11.8 billion by 2034, with a compound annual growth rate (CAGR) of 9.6%
during the 2025–2035 forecast period. The market is expected to grow due to the
growing emphasis on outsourcing by biotechnology and pharmaceutical companies
to cut costs and speed up drug discovery processes, as well as the demand for
specialized preclinical services, particularly in areas like genomics,
toxicology, and bioinformatics.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/preclinical-cro-market
GROWTH
DRIVERS
A major factor
driving the growing trend of pharmaceutical and biotechnology companies
outsourcing preclinical research activities to CROs is the cost reduction in
the ongoing rise in global R&D expenditures as companies increase their
R&D investments and seek out external partners with the infrastructure and
expertise to carry out preclinical studies efficiently. Complex medicines in
robust pipeline biopharmaceutical goods necessitate specialist testing, such as
pharmacology, toxicology, and safety assessment, which CRO provides.
Pharmaceutical
companies and government agencies have increased their investment in
preclinical studies to find effective treatments and vaccines for COVID-19 and
future infectious diseases. CROs have been instrumental in supporting these
efforts by providing testing services and expertise in virology and immunology.
Overall, as the world continues to address public health threats, the demand
for preclinical CRO services remains significant. The COVID-19 pandemic has
highlighted the importance of preclinical research in pandemic preparedness.
MARKET
SEGMENTATION:
· By
Service Type – Bioanalysis, Toxicology Testing, Compound Management
and Chemistry, Safety Pharmacology and Others
· By
Model type – Patient Derived Organoid (PDO) Model and Patient Derived
Xenograft (PDX) Model
· By
End User – Biopharmaceutical Companies, Government and Academics
Institutes and Medical Device Companies
· By
Region - North America, Europe, Asia Pacific, the Middle East and
Africa, and South America.
Global
Key Players:
· Bioneeds
· Jubilant
Biosys
· TheraIndx
· Eurofins
· Wuxi
Apptec
· Medpace
· Charles
River Laboratories
· PPD
· SGA
SA
· Intertek
Group
For More Information about this Report @
https://www.xresearch.biz/shop/preclinical-cro-market
About Us: -
xResearch
is a market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment